Evidence map›Paper›PMID 36281747›Full record

ArticleCytometry. Part A : the journal of the International Society for Analytical Cytology2023

Multiparameter analysis of human B lymphocytes identifies heterogeneous CD19

Erin M Wilfong, Katherine N Vowell, Leslie J Crofford, Peggy L Kendall

Open access · hybridAbstract read
In one paragraph

Article in Cytometry. Part A : the journal of the International Society for Analytical Cytology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Erin M WilfongDivision of Allergy, Pulmonary and Critical Care, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA.ORCID 0000-0002-6584-1578
Katherine N VowellDivision of Allergy, Pulmonary and Critical Care, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Leslie J CroffordDivision of Rheumatology and Immunology, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Peggy L KendallDivision of Allergy, Pulmonary and Critical Care, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA.ORCID 0000-0002-0516-654X
Vanderbilt University Medical Center · USWashington University in St. Louis · US

Funding

Tumor Immunology and Microenvironment Research ProgramP30CA068485 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI MATTHEW J TYSKA · 1995 to 2026
$172.8M
Vanderbilt Institute for Clinical and Translational Research (VICTR) -Identifying correlates of functional immunity in SARS-CoV-2 convalescent plasmaUL1TR002243 · NCATS · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Paul A. Harris, Wesley H Self · 2017 to 2026
$130.7M
Translational Analysis CoreP30DK058404 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI RICHARD M. PEEK · 2002 to 2026
$29.9M
Institutional Career Development CoreKL2TR002245 · NCATS · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Julie A. Bastarache · 2017 to 2026
$9.3M
Clinical and Translational Training Program in Pulmonary MedicineT32HL087738 · NHLBI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Lorraine B Ware · 2007 to 2026
$7.0M
Interdisciplinary Training in Rheumatic DiseasesT32AR059039 · NIAMS · VANDERBILT UNIVERSITY · PI Tracy Minan Frech, AMY S MAJOR · 2010 to 2026
$4.3M
Bruton's Tyrosine Kinase and Immune Tolerance in Type 1 DiabetesR01DK084246 · NIDDK · WASHINGTON UNIVERSITY · PI KENDALL, PEGGY L · 2011 to 2019
$3.2M
B Lymphocytes in Autoimmune DiseaseI01BX002882 · VA · VETERANS HEALTH ADMINISTRATION · PI KENDALL, PEGGY L · 2016 to 2025
–
BLRD VA I01 BX002882NCATS NIH HHS KL2 TR002245NCATS NIH HHS UL1 TR002243NCI NIH HHS P30 CA068485NHLBI NIH HHS T32 HL087738NIAMS NIH HHS T32 AR059039NIDDK NIH HHS P30 DK058404NIDDK NIH HHS R01 DK084246
6 · The paper itself

Abstract

Autoreactive B cell subsets have been described in a variety of settings, using multiple classification schemes and cell surface markers also found on healthy cells. CD19

Indexed as

B-LymphocytesB-Lymphocyte SubsetsAlgorithmsAntigens, CD19Flow CytometryHealthy VolunteersHumansReceptors, Complement 3dAntigens, CD19CD19 molecule, humanReceptors, Complement 3dautoreactive B cellsCD21lo B cellsflow cytometrysystemic sclerosis

Identifiers

PMID36281747
PMCPMC10085822
OpenAlexW4307229374

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.